Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training
Compass Pathways awarded U.S. grants to five organizations to develop healthcare-provider training programs for COMP360 psilocybin, preparing for an expected commercial launch if the treatment is approved. Recipients — CME Outfitters, Emory University, Fluence International, Integrative Psychiatry Institute, and Strata Mental Health Solutions — were selected through a competitive process and will retain independent ownership of their training content under ACCME standards for integrity and independence.
Key figures
- Grant recipients
- 5
- Trd patient population us
- ~4 million
- Originally planned recipients
- 3
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.